Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TMUS vs MRNA✓SelectedUSD · MRNATMUS vs MRNA performance historyLatest closeAs of+0.04%11/16
Stock and ETF performance explorer

TMUS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+172.2%
MRNA return
+878.5%
Excess return
-706.3%
Maximum drawdown
-44.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D0.0%-3.6%+3.7%0.0%
7D+0.8%-20.0%+20.7%+0.8%
30D+6.9%-1.3%+8.1%+6.8%
3M-6.4%+240.0%-246.3%-7.3%
6M-7.2%+339.0%-346.1%-8.5%
YTD-14.9%+630.0%-644.9%-17.1%
1Y-19.7%+769.1%-788.7%-22.1%
3Y+21.2%+181.2%-160.0%+19.4%
5Y+51.1%-8.1%+59.2%+51.9%
All+172.2%+878.5%-706.3%+152.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling